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Quantitative Magnetic Resonance Imaging in
Assessment of the Blood-Retinal Barrier
Walter E. Plehwe,*^: Donald W. McAobbie,t Richard A. Lerski.f and Eva M. Kohner*
Application of magnetic resonance imaging (MRI) in two-dimensional quantitative assessment of
blood-retinal barrier dysfunction was investigated in rabbits using a 0.1 T (4.25 MHz) resistive
system. Reliable and consistent measurements of vitreous Tl were obtained repeatedly, in slices of
width 5 mm and X-Y resolution of 1.2 mm. Calibration of reduction of Tl in eyes after injection of
gadolinium-DTPA (Gd-DTPA) was performed, resulting in a dose-related response of relaxation rate
(1/T1) to the dose of Gd-DTPA injected. Follow-up scans of injected eyes demonstrated a gradual
spread of the Tl "hot-spot" as the contrast agent diffused through the vitreous. Tl rose gradually to
basal levels by 72 hr. No local effect of Gd-DTPA was found by ophthalmoscopy. Xenon arc photoco-
agulation of rabbit retina reduced Tl from 1638 ± 54 (n = 6, mean ± SD) ms to 1408 ± 118 (n = 4)
msec (P < 0.01) throughout the vitreous 5-7 hr after treatment. In treated rabbits receiving 1.0
mmol/1 Gd-DTPA intravenously, Tl adjacent to lesions 90-120 min after injection was further re-
duced in a 63 nl voxel to 670 ± 50 ms (mean ± SD, n = 5) with a minimum pixel value of 285 ± 52 ms.
It was estimated that this represented leakage into vitreous of 8.3 nmol Gd-DTPA. Plasma Gd-DTPA
concentrations declined rapidly, with half-life of 20-40 min. The findings indicate that MRI is a
technique with the potential for repeated quantitative three-dimensional assessment of blood-retinal
barrier dysfunction. Invest Ophthalmol Vis Sci 29:663-670,1988
The initial lesions of diabetic retinopathy include
retinal capillary pericyte loss, endothelial cell prolifer-
ation, and microaneurysm formation.1 These
changes are accompanied by capillary dilatation and
increased capillary permeability due to disruption of
the inner blood-retinal barrier. While qualitative in-
creases in permeability are demonstrated readily by
fluorescein angiography, quantifying fluorescein
leakage by vitreous fluorophotometry continues to be
subject to several practical problems. These include
the age-related reduction in light transmission by the
lens, the necessity for clear optic media,2"4 an intact
vitreous gel5 and the restriction with current fluoro-
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photometers (eg, the Fluorotron Master, Coherent
Radiation, Palo Alto, CA) to assessment of leakage in
one dimension from the perimacular area of retina
anteriorly (ref. 6, and Plehwe WE, unpublished data).
In the absence of differential spectrofluorophoto-
metry, it must be assumed that the transport rates of
free (non-protein-bound) fluorescein and its major
metabolite (fluorescein glucuronide) into, and out of
the vitreous, are identical.7'8
Since many of the lesions of diabetic retinopathy
are observed in the mid-periphery, and may be com-
paratively severe in the presence of relatively mild
disease in the macular field,9 application of a tech-
nique with three-dimensional capability such as mag-
netic resonance imaging (MRI) provided an opportu-
nity for more complete assessment of blood-retinal
barrier dysfunction in individual cases.
MRI has been used to examine the anatomy and
pathology of the eye, and very encouraging images
with contrast and spatial resolution equivalent to,
and in some cases superior in quality to those of early
X-ray CT scanners have been obtained.10"16 Appro-
priate selection of scanning parameters has allowed
areas of particular interest to be emphasized, with
suggestions of blood-retinal barrier dysfunction in
some cases1516 but in few studies only has quantita-
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tive determination of altered relaxation times (Tl
[spin-lattice or longitudinal relaxation time] and T2
[spin-spin or transverse relaxation time]) been at-
tempted.17 The relaxation times on proton scanning
of vitreous are extremely long, reflecting its high con-
tent of water (98.5%18). By direct analogy to the use of
fluorescein during vitreous fluorophotometry, the
availability of contrast agents for use in association
with MRI afforded the possibility of measuring
blood-retinal barrier dysfunction in the whole eye. Of
the contrast agents which have been described,19
paramagnetic substances, which alter the local mag-
netic environment (eg, gadolinium) have the poten-
tial to enhance proton relaxation and thereby shorten
Tl and T2. While it is possible to produce T2-
weighted images in vivo, direct quantitative measure-
ment of long T2 times with the magnetic resonance
scanners currently available is extremely difficult
technically.
This study was undertaken in order to explore the
feasibility of the use of MRI as an investigational
technique for quantifying the disruption of the
blood-retinal barrier(s), by measurement of the relax-
ation time, Tl, in selected volumes of rabbit vitreous
in vivo after administration of gadolinium. In the




Adult pigmented rabbits (2.9-4.5 kg) were used ex-
clusively in this study. For all ocular manipulations,
animals were sedated with intramuscular fentanyl/
fluanisone (Hypnorm, Crown Chemical Co., Lam-
berhurst, England), 0.4 ml/kg, followed by 2-6 mg/kg
intravenous pentobarbitone (Sagatal, May and
Baker, Dagenham, England). Where necessary,
pupils were dilated with 1% cyclopentolate HC1 and
10% phenylephrine HC1 (Smith and Nephew Phar-
maceuticals, Romford, England). All investigations
described in this paper were carried out in accordance
with the ARVO Resolution on the Use of Animals in
Research.
Magnetic Resonance Imaging
Scans were performed by the two-dimensional
Fourier transform technique at 4.25 MHz on a 0.1
tesla resistive system, which has been described pre-
viously.20 Contiguous 5 mm multi-slice scans were
performed using saturation recovery with TR = 500
ms and field echo acquisition. For the quantitation of
Tl, single-slice (width 5 mm) images were generated
using inversion recovery with TR = 3000 ms and Tl
= 1000 ms, and saturation recovery with TR = 2000
ms. For each voxel, the signal intensity of the inver-
sion recovery scan was divided by that of the satura-
tion recovery scan and the computed Tl value for
this quotient was obtained from tables of Tl, derived
from standard equations.21 The receiver was a three-
turn surface spiral coil, wound from 5 mm solid cop-
per wire, with a final outer diameter of 75 mm and an
inner diameter of 25 mm, aligned with its axis per-
pendicular to the axis z, of the magnetic field, Bo. The
receiver coil remained in a fixed position to avoid
possible interaction with the transmitter coil. Scan
resolution was 128 X 128 pixels over a 150 X 150 mm
field of view. A glass vial containing a solution of
gadolinium [III] chloride, GdCl3, with Tl of 1600
msec at 25°C was placed adjacent to the coil to act as
an internal quantitative standard. Any scan in which
Tl of the standard differed by more than 10% from
its true value was not used for quantitative purposes.
The accuracy of computed Tl was assessed over the
range 300-2000 ms using agarose gels calibrated in a
Bruker (Coventry, UK) minispec pc 8 spectrometer
operating at 8 MHz.21
Effect of Gadolinium on Vitreous Relaxation Times
To measure the efficacy of gadolinium as a contrast
agent in MRI of the eye, 0.25-1.0 jumole of gadolin-
ium-diethylene triamine pentaacetic acid (Gd-
DTPA) in 50 fx\, diluted in 0.9% normal saline, was
injected directly through the pars plana into the mid-
vitreous, and MRI performed 5-6 hr later. Vitreous
was not aspirated prior to injection, and eyes were
examined by indirect ophthalmoscopy to exclude ret-
inal artery or vein occlusion. This compound was
used in preference to GdCl3, due to the high toxicity
of the inorganic compound. This time period was
selected initially to allow diffusion of the agent in
order to try to achieve a uniform concentration of
Gd-DTPA in the mid-vitreous. Eyes were examined
by indirect ophthalmoscopy at daily intervals for the
appearance of any localized reaction to the contrast
agent. Following the initial scans, MRI was repeated
at 24, 48 and 72 hr after injection of 1.0 ^mole Gd-
DTPA to determine the fate of the contrast agent in
the vitreous.
Disruption of the Blood-Retinal Barrier
Lesions in the blood-retinal barrier were created in
deeply anesthetized animals by the application of 12
(n = 2 rabbits) or 40 (n = 9) xenon arc photocoagula-
tion burns (O'Malley Light Coagulator, Clinitex Inc,
Danvers, MA; power setting 2, duration 1.0 second,
pupil diaphragm 8 mm diameter). In order to allow
ready distinction between treated and normal retina,
and to preserve the animals' vision, burns were
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placed in a group either above or below the posterior
pole of the eye. At 4-6 hr after recovery from anesthe-
sia, rabbits were given 0.25 (n = 2) or 1.0 (n = 5)
mmole/kg Gd-DTPA intravenously, and were re-
anesthetized prior to performing MRI at 90-120 min.
To ensure survival, it was found necessary to allow
animals to recover from the initial anesthesia prior to
administration of the large volume (2.0 ml/kg) of hy-
pertonic solution (500 mmole/1) of Gd-DTPA. Four
rabbits did not receive Gd-DTPA after photocoagula-
tion, and acted as controls.
To assess the time course of Gd-DTPA clearance
from the circulation such that an indication of the
optimal time for scanning could be obtained, blood
was sampled from two rabbits at intervals until the
completion of MRI, and T1 was measured in plasma
in vitro in a Bruker minispec pc 8 benchtop spec-
trometer operating at 8 MHz and 25°C. Standards
were prepared by addition of known amounts of Gd-
DTPA to rabbit plasma.
Statistical Methods
The significance of differences between groups was
assessed by student unpaired t-test. Data from one
eye only for each animal were used.
Results
Calibration and Validation of Tl Measurements
Calibration of the system over the range 300-2000
msec using agarose gels indicated that 95% confi-
dence limits for computed T1 were within 10% of the
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Fig. 1. Calibration of 0.11 resistive system as used for T1 over the
range 300-2000 msec, using agarose gels as standards. Values are
given as 95% confidence intervals.
Fig. 2. (A) Representative inversion recovery (IR) scan of a con-
trol eye. (B) Representative saturation recovery (SR) scan of the
control eye shown in (A). (C) Computed Tl image derived from
scans (A) and (B). The circular object (upper right) in the SR scan
and computed Tl image is the internal standard. In each image, the
arrow indicates the lens and the arrowhead indicates the vitreous.
Effect of Gd-DTPA Injection into Rabbit Vitreous
Inversion recovery scans of control eyes without
Gd-DTPA showed the posterior vitreous clearly de-
marcated from the retina-choroid-sclera and extraoc-
ular tissues (Fig. 2A). Similarly, the lens bordered the
anterior vitreous, and was itself distinguished from
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Fig. 3 . Relationship between dose of Gd-DTPA injected directly
into the rabbit vitreous, and the relaxation rate (1/Tl). Values are
given as 95% confidence intervals.
the anterior chamber. Computed Tl in the vitreous
was 1638 ± 54 ms (mean ± S.D., n = 6), and changed
abruptly at the posterior vitreous boundary to 545
± 17 ms (n = 5) in the region corresponding to the
extraocular tissues. Representative saturation recov-
ery and computed Tl scans are shown in Figure 2B
andC.
Intravitreal injection of 0.25-1.0 /imole Gd-DTPA
in 50 /xl did not cause retinal vascular occlusion in
any eye. Inversion recovery scans of these eyes 5-6 hr
after injection demonstrated a white area in the mid-
vitreous, gradually fading to black at the periphery of
the vitreous. These white areas corresponded to a re-
duction of Tl to 180 ± 81 ms (mean ± S.D.) ms (n
= 3) for the maximum dose. The response curve of
relaxation rate (1 /T1) to dose of Gd-DTPA injected is
shown in Figure 3. The approximate half-maximal
response in relaxation rate occurred at 0.6 /nmole
Gd-DTPA. A representative inversion recovery scan
and its computed Tl image are shown in Figure 4A
and B. Repeated examination of injected eyes by in-
direct ophthalmoscopy revealed no macroscopic re-
action to the administered contrast agent.
Temporal Response of Vitreous Tl After
Gd-DTPA Injection
Repeated MRI (inversion recovery and saturation
recovery scans) of eyes which had received 1.0 ^mole
Gd-DTPA showed a progressive increase in com-
puted Tl values, achieving basal levels by 72 hr (Fig.
5). The initial "hot-spot" corresponding to the local-
ized volume of Gd-DTPA spread gradually, presum-
ably due to diffusion of Gd-DTPA throughout the
vitreous.
Tl Changes After Disruption of the
Blood-Retinal Barrier
In four control rabbits treated with 40 xenon arc
photocoagulation burns in the lower half of the poste-
rior pole, Tl of the vitreous 7 hr after treatment was
reduced significantly to 1408 ± 118 ms (P < 0.01),
and a gradient was found in one, rising from 1161 ms
adjacent to the lesions to normal (1603 ms) at the
vitreous base superoanteriorly. The appearances of
the IR scan and the computed Tl image remained
unchanged from those of untreated eyes. In two rab-
bits, MRI was performed at 72 hr after photocoagula-
tion, and Tl values were again normal (1630, 1650
ms). In preliminary experiments, two rabbits were
given 0.25 mmole/kg Gd-DTPA 24 hr after applica-
tion of 12 xenon arc photocoagulation burns, and
MRI performed 6 hr thereafter. However, results
were equivocal, and five rabbits were then treated
with 40 photocoagulation burns, and 6 hr later re-
Fig. 4. (A) IR scan of rabbit eye 4 hr after direct injection of 0.5
fimole Gd-DTPA in 50 (il. (B) Computed Tl image derived from
scan (A). In each image, the arrow indicates the region of reduced
Tl corresponding to injected Gd-DTPA.
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ceived 1.0 mmole/kg Gd-DTPA intravenously. MRI
performed at 90-120 min revealed leakage of con-
trast agent through the treated area of retina, appear-
ing as a bright white concavity in the normal black
vitreous on inversion recovery scans. Computed Tl
in a nine pixel (63 /ul voxel) region of interest was 670
± 50 ms, with a mean minimum pixel value in this
region of 285 ± 52 ms. The mean computed Tl in
vitreous away from the region of obvious leakage
with extremely low T1 was 1460 ± 60 ms. A represen-
tative inversion recovery scan and its computed Tl
image are shown in Figure 6A and B,
Plasma Tl in Rabbits Receiving Gd-DTPA
Relaxation rate (1/T1) increased linearly in vitro
with the concentration of Gd-DTPA to 5 mmol/1 in
plasma (Fig. 7). This permitted estimates of the con-
centration of circulating Gd-DTPA to be made, as
relaxation rate declined during the 2 hr of study (Fig.
8). The estimated half-life was 20-40 min, but was
not constant over time.
Discussion
In order to allow the use of MRI in assessments of
the integrity of the blood-retinal barrier, reliability
and consistency of the Tl data had to be demon-
strated. This was done in two ways. Initially, the ma-
chine was calibrated with agarose gels of which the T1
had been determined independently, and Tl data
were found to be consistent and reliable over the re-
quired range, almost to Tl of water (2650 ms at
25°C). Second, the use of the internal standard in
2000
Time (hours)
Fig. 5. Temporal response of Tl in eyes which received 1.0
-DTPA by direct injection at time = 0 hr.
Fig. 6. (A) Representative IR scan of a rabbit eye 120 min after
intravenous injection of 1.0 mmole/kg Gd-DTPA. The eye was
treated 7 hr earlier with 40 photocoagulation burns applied to the
lower half of the posterior pole in the region of reduced Tl indi-
cated by the arrow. (B) Computed Tl image derived from scan (A).
scans ensured that any data obtained could be used
confidently. Applicability of the system with the
imaging sequences as designated (for long Tl and
long T2) was then assessed in the rabbit in vivo and
long Tl values, consistent with the high water con-
tent, were obtained repeatedly for rabbit vitreous.
This finding opened the possibility of measuring
blood-retinal barrier dysfunction over the entire reti-
nal surface by systemic administration of a paramag-
netic substance which would enhance vitreous water
proton relaxation after leakage through the barrier in
a manner analogous to measurement of fluorescein
in vitreous fluorophotometry. It may not be possible
to extrapolate these data directly to eyes of other spe-
cies, in which vitreous collagen content may be quite
different (eg, bovine eyes).
In order to use Gd-DTPA in a manner analogous
to fluorescein, calibration of Tl changes with known
amounts of Gd-DTPA injected directly into the eye
was performed. The volume of Gd-DTPA solution
injected in each case (50 JLII) was insufficient to cause
Downloaded from iovs.arvojournals.org on 06/29/2019








0 1 2 3 4 5
Gadolinium concentration (mmol/l)
Fig. 7. Relaxation rate (1/T1) as a function of concentration of
Gd-DTPA in rabbit plasma.
retinal artery or vein occlusion, and itself changed the
volume of vitreous by less than 5%.22 However, intra-
ocular pressure was not measured directly. Over the
range of Gd-DTPA injected (0.25-1.0 jumole), dose-
related response of relaxation rate (1/T1) to Gd-
DTPA was obtained, allowing quantitative estimates
of Gd-DTPA leakage into the vitreous to be made, in
situations where the background T1 was normal.
Repeated scanning of eyes which had received the
largest dose showed a gradual spread of the reduced
Tl "hot-spot" presumably due to diffusion of Gd-
DTPA throughout the vitreous, and a homogeneous
image with uniform Tl was present 24 hr after injec-
tion. Follow-up after longer time intervals demon-
strated a gradual increase of T1, achieving basal levels
by 72 hr. This is similar to the time course of the loss
of fluorescein from the eye, which is in part trans-
ported actively. The molecular weight of Gd-DTPA




Fig. 8. Concentration of Gd-DTPA, derived from relaxation rate
(1/T1) (Fig. 7) in plasma of two rabbits as a function of time after
intravenous injection of 1.0 mmole/kg Gd-DTPA.
fluorescein, fluorescein monoglucuronide (508 Da24),
but on a structural basis, it is unlikely that Gd-DTPA
is transported by a similar carrier. Further investiga-
tions are required to determine the mode of egress of
this agent from the eye. However, if this time course
also applies in the human eye, Gd-DTPA could be
used repeatedly for assessments of blood-retinal bar-
rier dysfunction. Whether other, even more stable
gadolinium complexes are removed similarly (eg,
gadolinium cryptelates25 remains to be determined.
Kinetics of Gd-DTPA in the vitreous would most
likely be affected by posterior vitreous detachment or
syneresis of vitreous, as is the case with fluorescein;
however, the effect of these alterations was not inves-
tigated in this study. Repeated ophthalmoscopic ex-
amination of injected eyes did not reveal any local-
ized macroscopic reaction to Gd-DTPA. Subtle bio-
chemical or biophysical alterations in retinal function
were not excluded, and further, more detailed studies
may be required to exclude possible toxic local ef-
fects.
Measurement of vitreous Tl in eyes that had un-
dergone photocoagulation 5-8 hr previously indi-
cated a reduction of approximately 14% from basal
values, which indicated that in any clinical studies of
blood-retinal barrier dysfunction or of uveitis, the
basal Tl of vitreous must be taken into consider-
ation. Three days after photocoagulation, Tl values
were again normal. This reduction of T1 may be a
consequence of raised protein concentration locally
in the vitreous, after leakage across the disrupted ret-
ina, and improvement of this leakage by 3 days may
explain the normal Tl values obtained at this time.
An effect of shortened relaxation times attributable to
protein leakage was described qualitatively in cases of
uveal melanoma,15 but would be difficult to quantify
directly without the use of a contrast agent such as
gadolinium, of which the specific activity in reducing
Tl is known or may be calculated.
In contrast, in those animals scanned 90-120 min
after receiving Gd-DTPA intravenously, Tl was re-
duced by up to 80% immediately adjacent to the area
of photocoagulation, with rising values as distance
from the lesions increased. Tl values anteriorly, and
on the opposite side of the globe, were normal or near
normal. Since photocoagulation reduced vitreous Tl
significantly, the calibration data obtained previously
could not be applied directly to calculate leakage of
Gd-DTPA into the vitreous. From theoretical consid-
erations,26 it was possible to calculate the amount of
Gd-DTPA entering the vitreous, and to compare this
with fluorescein concentrations obtained in rabbits
by vitreous fluorophotometry. In considering the ef-
fect of a paramagnetic substance (concentration M),
with q hydration sites and affecting the relaxation of
water protons:
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1 1 qM
Tlobs" Tlfree + NTlm (1)
Tlobs is Tl in the presence of the paramagnetic sub-
stance, T1 free is T1 in the absence of the paramag-
netic substance, N is the concentration of water, and
Tim is the relaxation constant for protons in water
molecules in close proximity to gadolinium and has a
value of 12.3 /tsec at 4 MHz (derived from ref. 27).
In the case of Gd-DTPA approaching water mole-
cules in vitreous, q = 4, and if the vitreous content of
water is 98.5%,17 N = 55.0 mol/1. Vitreous Tlfree
after photocoagulation, prior to administration of
Gd-DTPA was 1408 ms, and Tlobs (after Gd-DTPA
injection) was 670 ms. It follows that in 63 n\, the
concentration of Gd-DTPA was 132 jumol/1, with a
total of 8.3 nmol Gd-DTPA detected.
In rabbits treated with xenon arc photocoagula-
tion, and given 14 mg/kg (37 /umole/kg) sodium fluo-
rescein, homogeneous concentrations of fluorescent
material equivalent to 50-100 ng/ml fluorescein were
detectable by vitreous fluorophotometry 6 hr after
intravenous administration of fluorescein (Plehwe
WE, et al, unpublished data). Since approximately
two-thirds of this material is present as fluorescein
glucuronide,8 of which the fluorescence is 18% that of
fluorescein, the estimated amount of fluorescein and
fluorescein glucuronide in a rabbit vitreous of 1.3 ml
volume under these conditions is 0.4-0.8 nmol.
However the dose of Gd-DTPA given was 27-fold
higher than the dose of fluorescein, and assuming
that in this model both free and protein-bound fluo-
rescein may enter the vitreous, a total of 11-22 nmol
of fluorescein and its glucuronide might be present in
the eye, if the higher dose were given. This estimate is
comparable to the amount of Gd-DTPA detected
(8.3 nmol).
From the data presented and from theoretical con-
siderations, it is clear that the sensitivity of MRI in
detection of Gd-DTPA by the reduction of vitreous
T1 is considerably lower than that for the detection of
fluorescent material by vitreous fluorophotometry, in
which concentrations equivalent to 2 ng/ml (5 nmol/
1) fluorescein may be distinguished reliably from zero.
With the equipment used for MRI, a reduction in Tl
of at least two standard deviations (108 ms) from the
mean of normal, corresponding to 6.77 /umol/1 Gd-
DTPA would be required, indicating a 1200-fold
lower sensitivity at the lower limit of detection. The
half-maximal response in vitreous fluorophotometry
is obtained at approximately 500 ng/ml (1.33 jumol/
1). Using equation (1) above, 50% reduction in Tl
occurs with 103.5 ^mol/1 Gd-DTPA, suggesting a
rightward shift of the dose-response curve in compar-
ison with that of fluorescein by a factor of 78. Im-
proved resolution with apparatus of higher magnetic
field strength may allow even better consistency in
results to be obtained, and increase the sensitivity of
detection of the contrast agent at very low concentra-
tions.
By examination of the dynamic changes of Tl in
plasma, the rate of disappearance of Gd-DTPA was
comparable to the estimates of others in rats23 and to
the rate of disappearance of free (non-protein-bound)
fluorescein.28 Since circulating concentrations of Gd-
DTPA 2 hr after injection were approximately 10% of
the initial concentration, it seems that little or no
additional information would be obtained by in-
creasing the time between administration of the agent
and commencing MRI. Whether the time interval
selected (90-120 min) is optimal has not yet been
determined.
The xenon arc photocoagulation model used to ex-
amine effects of retinal disruption in this study causes
a major, although temporary disruption of the retina,
which is not directly comparable with the chronic
dysfunction of the blood-retinal barrier in clinical
conditions such as diabetic retinopathy, in which
sensitive quantitative diagnosis is required. Improved
sensitivity of the technique may allow its application
in other experimental models, and eventually its in-
troduction in clinical assessments.
In summary, the use of MRI in assessment of
blood-retinal barrier dysfunction has been investi-
gated. This technique offers at least two potential ad-
vantages over the traditional method, vitreous fluoro-
photometry, in that assessments may be made in at
least two dimensions rather than one, and the
method does not require the presence of clear optic
media. The contrast agent used in this study, Gd-
DTPA, is removed rapidly from the rabbit eye, and
offers the potential for the procedure to be repeated at
intervals. At present, MRI is a relatively lengthy pro-
cedure, and its sensitivity in detection of the contrast
agent used remains considerably lower than the sensi-
tivity for detection of fluorescein by vitreous fluoro-
photometry. Further work is required to realize the
full potential of the technique.
Key words: magnetic resonance imaging, Tl measurement,
gadolinium-DTPA, blood-retinal barrier, rabbit
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